Global Lungs in Vitro Market Size by Type (2D Cell Models, 3D Cell Models) and Regional Forecasts 2017-2025

June 2018 | 120 pages | ID: G5FAFEEFBD5EN
Bizwit Research & Consulting LLP

Abstracts

Global Lungs in Vitro Market to reach USD 601.3 million by 2025.

Global Lungs in Vitro Market valued approximately USD 138.7 million in 2016 is anticipated to grow with a healthy growth rate of more than 17.7% over the forecast period 2017-2025 Focus on developing alternatives for animal testing models, advancements in 3D cell culture technology, and the development of new 3D in vitro models are factors driving the growth of this market.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• 2D Cell Models
• 3D Cell Models
• Commercial 3D Cell Models
• Inhouse 3D Cell Models

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025

Some of the key manufacturers involved in the market are, ATCC, Lonza, Epithelix, Mattek, Emulate, Tissuse, Mimetas, Insphero, Cn Bio Innovations. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.

Target Audience of the Global Lungs in Vitro in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL LUNGS IN VITRO MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL LUNGS IN VITRO MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL LUNGS IN VITRO MARKET, BY TYPE

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Lungs in Vitro Market, Sub Segment Analysis
  5.3.1. 2D Cell Models
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. 3D Cell Models
    5.3.2.1. Commercial 3D Cell Models
    5.3.2.2. Inhouse 3D Cell Models
    5.3.2.3. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.4. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL LUNGS IN VITRO MARKET, BY REGIONAL ANALYSIS

6.1. Lungs in Vitro Market, Regional Market Snapshot (2015-2025)
6.2. North America Lungs in Vitro Market Snapshot
  6.2.1. U.S.
    6.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.2.2. Canada
    6.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3. Europe Lungs in Vitro Market Snapshot
  6.3.1. U.K.
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Germany
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.3. France
    6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.4. Rest of Europe
    6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4. Asia Lungs in Vitro Market Snapshot
  6.4.1. China
    6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.2. India
    6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.3. Japan
    6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.4.4. Rest of Asia Pacific
    6.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.5. Rest of The World
  6.5.1. South America
    6.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.5.2. Middle East and Africa
    6.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. COMPETITIVE INTELLIGENCE

7.1. Company Market Share (Subject to Data Availability)
7.2. Top Market Strategies
7.3. Company Profiles
  7.3.1. ATCC
    7.3.1.1. Overview
    7.3.1.2. Financial (Subject to Data Availability)
    7.3.1.3. Product Summary
    7.3.1.4. Recent Developments
  7.3.2. Lonza
  7.3.3. Epithelix
  7.3.4. Mattek
  7.3.5. Emulate
  7.3.6. Tissuse
  7.3.7. Mimetas
  7.3.8. Insphero
  7.3.9. Cn Bio Innovations